Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial
OrthoSpineNews
JANUARY 16, 2025
DUBLIN, January 15, 2025–( BUSINESS WIRE )–Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain. Assessment of the patients will continue for an additional year.
Let's personalize your content